A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

Clinical trial NCT07570758 · RECRUITING

Trial details

NCT number: NCT07570758
Sponsor: ERX Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity & Overweight

Start date: 2026-05-28
Primary completion: 2027-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.